[The efficacy, complications and prospects for the vaccinal prevention of tuberculosis].
Gizatulina
N M
NM
Lomonosov State University, Moscow, Russia.
D001500:BCG Vaccine / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D014943:Global Health; D006801:Humans; D014376:Tuberculosis / Q000517:prevention & control*
D001500:BCG Vaccine
Effektivnost', oslozhneniia i perspektivy vaktsinoprofilaktiki tuberkuleza.